{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T06:17:28Z","timestamp":1788675448058,"version":"build-2803163510"},"reference-count":16,"publisher":"Japanese Society of Internal Medicine","issue":"18","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2025,9,15]]},"DOI":"10.2169\/internalmedicine.5114-24","type":"journal-article","created":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T17:12:40Z","timestamp":1741367560000},"page":"2760-2763","source":"Crossref","is-referenced-by-count":1,"title":["Development of Adult T-Cell Leukemia\/Lymphoma During Treatment with PD-L1 Inhibitor for Lung Cancer"],"prefix":"10.2169","volume":"64","author":[{"given":"Hikari","family":"Fujioka","sequence":"first","affiliation":[{"name":"Fourth Department of Internal Medicine, Teikyo University Mizonokuchi Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Kikuchi","sequence":"additional","affiliation":[{"name":"Fourth Department of Internal Medicine, Teikyo University Mizonokuchi Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takumi","family":"Nakahara","sequence":"additional","affiliation":[{"name":"Fourth Department of Internal Medicine, Teikyo University Mizonokuchi Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Yoshioka","sequence":"additional","affiliation":[{"name":"Fourth Department of Internal Medicine, Teikyo University Mizonokuchi Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rina","family":"Kawai","sequence":"additional","affiliation":[{"name":"Fourth Department of Internal Medicine, Teikyo University Mizonokuchi Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maki","family":"Kajitani","sequence":"additional","affiliation":[{"name":"Fourth Department of Internal Medicine, Teikyo University Mizonokuchi Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mana","family":"Ishizuka","sequence":"additional","affiliation":[{"name":"Fourth Department of Internal Medicine, Teikyo University Mizonokuchi Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaya","family":"Akiyama","sequence":"additional","affiliation":[{"name":"Fourth Department of Internal Medicine, Teikyo University Mizonokuchi Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaro","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Fourth Department of Internal Medicine, Teikyo University Mizonokuchi Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayako","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Fourth Department of Internal Medicine, Teikyo University Mizonokuchi Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Sato","sequence":"additional","affiliation":[{"name":"Fourth Department of Internal Medicine, Teikyo University Mizonokuchi Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kennosuke","family":"Karube","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Graduate School of Medicine, Nagoya University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goh","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Fourth Department of Internal Medicine, Teikyo University Mizonokuchi Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Kohyama","sequence":"additional","affiliation":[{"name":"Fourth Department of Internal Medicine, Teikyo University Mizonokuchi Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Pardoll DM. The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer 12: 252-264, 2012.","DOI":"10.1038\/nrc3239"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Zhong L, Wu Q, Chen F, Liu J, Xie X. Immune-related adverse events: promising predictors for efficacy of immune checkpoint inhibitors. Cancer Immunol Immunother 70: 2559-2576, 2021.","DOI":"10.1007\/s00262-020-02803-5"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Spigel DR, Faivre-Finn C, Gray JE, et al. Five-year survival outcomes from the PACIFIC trial: durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer. J Clin Oncol 40: 1301-1311, 2022.","DOI":"10.1200\/JCO.21.01308"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4. Yoshie O, Fujisawa R, Nakayama T, et al. Frequent expression of CCR4 in adult T-cell leukemia and human T-cell leukemia virus type 1-transformed T cells. Blood 99: 1505-1511, 2002.","DOI":"10.1182\/blood.V99.5.1505"},{"key":"5","unstructured":"5. Atsumi K, Matsumoto M, Yamashita M, et al. A case of adult T-cell leukemia\/lymphoma showing CD8 positive and CD25 negative by immunohistochemistry. Shindan Byouri (Jpn J Diagn Pathol) 41: 349-354, 2024 (in Japanese)."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Takatori M, Sakihama S, Miyara M, et al. A new diagnostic algorithm using biopsy specimens in adult T-cell leukemia\/lymphoma: combination of RNA in situ hybridization and quantitative PCR for HTLV-1. Mod Pathol 34: 51-58, 2021.","DOI":"10.1038\/s41379-020-0635-8"},{"key":"7","unstructured":"7. Nakamura T, Yasunaga JI, Yokoo K, et al. [Adult T-cell leukemia\/lymphoma diagnosed by RNA <i>in situ<\/i> hybridization for HTLV-1 bZIP factor]. Rinsho Ketsueki (Jpn J Clin Hematol) 63: 89-93, 2022 (in Japanese)."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Iwanaga M. Epidemiology of HTLV-1 infection and ATL in Japan: an update. Front Micobiol 11: 1124, 2020.","DOI":"10.3389\/fmicb.2020.01124"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Kato T, Imaizumi Y, Miyazaki Y. Nationwide hospital-based survey of adult T-cell leukemia\/lymphoma in Japan. Viruses 14: 791, 2022.","DOI":"10.3390\/v14040791"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Wartewig T, Kurgyis Z, Keppler S, et al. PD-1 is a haploinsufficient suppressor of T cell lymphomagenesis. Nature 552: 121-125, 2017.","DOI":"10.1038\/nature24649"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Ratner L, Waldmann TA, Janakiram M, Brammer JE. Rapid progression of adult T-cell leukemia-lymphoma after PD-1 inhibitor therapy. N Engl J Med 378: 1947-1948, 2018.","DOI":"10.1056\/NEJMc1803181"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Ishitsuka K, Utsunomiya A, Ishida T. PD-1 inhibitor therapy in adult T-cell leukemia-lymphoma. N Engl J Med 379: 695, 2018.","DOI":"10.1056\/NEJMc1807852"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Yoneshima Y, Kato K, Minami H, et al. HTLV-1 seropositive patients with lung cancer treated with PD-1 inhibitors. Cancer Sci 111: 3395-3396, 2020.","DOI":"10.1111\/cas.14536"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Misawa K, Yasuda H, Matsuda H, et al. Development of acute adult T-cell leukemia following PD-1 blockade therapy for lung cancer. Intern Med 61: 3421-3424, 2022.","DOI":"10.2169\/internalmedicine.9405-22"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Yoshida M, Seiki M, Yamaguchi K, Takatsuki K. Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease. Proc Natl Acad Sci U S A 81: 2534-2537, 1984.","DOI":"10.1073\/pnas.81.8.2534"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Wada Y, Sato T, Hasegawa H, et al. RAISING is a high-performance method for identifying random transgene integration sites. Commun Biol 5: 535, 2022.","DOI":"10.1038\/s42003-022-03467-w"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/18\/64_5114-24\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T03:28:40Z","timestamp":1758338920000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/18\/64_5114-24\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,15]]},"references-count":16,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.5114-24","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,15]]},"article-number":"5114-24"}}